These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 14680506)

  • 1. Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.
    Foey AD; Field S; Ahmed S; Jain A; Feldmann M; Brennan FM; Williams R
    Arthritis Res Ther; 2003; 5(6):R317-28. PubMed ID: 14680506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM; Barnes PJ; Giembycz MA
    Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of IL-15-stimulated TNF-alpha production by rolipram.
    Kasyapa CS; Stentz CL; Davey MP; Carr DW
    J Immunol; 1999 Sep; 163(5):2836-43. PubMed ID: 10453029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
    Seldon PM; Barnes PJ; Meja K; Giembycz MA
    Mol Pharmacol; 1995 Oct; 48(4):747-57. PubMed ID: 7476903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conventional protein kinase C and atypical protein kinase Czeta differentially regulate macrophage production of tumour necrosis factor-alpha and interleukin-10.
    Foey AD; Brennan FM
    Immunology; 2004 May; 112(1):44-53. PubMed ID: 15096183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation.
    Jimenez JL; Punzón C; Navarro J; Muñoz-Fernández MA; Fresno M
    J Pharmacol Exp Ther; 2001 Nov; 299(2):753-9. PubMed ID: 11602691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.
    Verghese MW; McConnell RT; Strickland AB; Gooding RC; Stimpson SA; Yarnall DP; Taylor JD; Furdon PJ
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1313-20. PubMed ID: 7891349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis.
    Sebbag M; Parry SL; Brennan FM; Feldmann M
    Eur J Immunol; 1997 Mar; 27(3):624-32. PubMed ID: 9079801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of tumor necrosis factor alpha production by cAMP in human monocytes: dissociation with mRNA level and independent of interleukin-10.
    Shames BD; McIntyre RC; Bensard DD; Pulido EJ; Selzman CH; Reznikov LL; Harken AH; Meng X
    J Surg Res; 2001 Aug; 99(2):187-93. PubMed ID: 11469886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine differentially regulates interleukin-10, interleukin-15, and tumor necrosis factor a production by rheumatoid synoviocytes.
    Cho ML; Kim WU; Min SY; Min DJ; Min JK; Lee SH; Park SH; Cho CS; Kim HY
    Arthritis Rheum; 2002 Jan; 46(1):42-51. PubMed ID: 11817607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis.
    Navikas V; Matusevicius D; Söderström M; Pirskanen R; Fredrikson S; Link H
    Clin Neuropharmacol; 1998; 21(4):236-44. PubMed ID: 9704165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
    Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
    Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
    Matsumori A; Ono K; Sato Y; Shioi T; Nose Y; Sasayama S
    J Mol Cell Cardiol; 1996 Dec; 28(12):2491-9. PubMed ID: 9004165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors.
    Gantner F; Kupferschmidt R; Schudt C; Wendel A; Hatzelmann A
    Br J Pharmacol; 1997 May; 121(2):221-31. PubMed ID: 9154331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy.
    Cheng JB; Watson JW; Pazoles CJ; Eskra JD; Griffiths RJ; Cohan VL; Turner CR; Showell HJ; Pettipher ER
    J Pharmacol Exp Ther; 1997 Feb; 280(2):621-6. PubMed ID: 9023272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-alpha production and expression of B7-1 in human monocyte-derived antigen-presenting cells.
    Probst P; Skeiky YA; Steeves M; Gervassi A; Grabstein KH; Reed SG
    Eur J Immunol; 1997 Oct; 27(10):2634-42. PubMed ID: 9368620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
    Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
    Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.